This article is for informational purposes only and does not constitute medical advice. GLP-1 medications, ED medications, and the other prescription products discussed here are prescription drugs. Eligibility requires evaluation by a licensed healthcare professional and is not guaranteed. Compounded medications discussed here are not FDA-approved finished products. Pricing information reflects published rates at the time of writing and is subject to change — confirm current terms directly with each platform before enrolling. This article contains affiliate links.
Why This Comparison Exists
Most telehealth comparison articles focus on a single category — GLP-1-specialist platforms compared against other GLP-1-specialist platforms, hair loss platforms compared against other hair loss platforms. That works if you only need one thing. It works less well if you're a real patient who's already thinking about GLP-1 access and might also want hair loss treatment, or wants to handle ED prescriptions through the same login, or is curious about what the daily health injection category actually is.
This comparison is for that patient. Refills Health, MEDVi, and LifeMD all operate as multi-vertical or diversified telehealth platforms. They overlap on GLP-1 but they do not have identical structures, and the differences matter when you're choosing where to send your prescription.
For my full standalone Refills Health review, see: Refills Health Review 2026.
The 2026 Context Every Comparison Needs to Start With
All three platforms in this comparison offer access to compounded GLP-1 medications for at least some patients. Before evaluating platform-vs-platform differences, the same baseline applies: the FDA resolved the GLP-1 drug shortages in 2024 and early 2025, and the regulatory rules around compounding these medications have shifted as a result. Post-shortage, the FDA has drawn sharper lines around mass-produced compounded versions of semaglutide and tirzepatide, and the agency has been issuing warning letters to platforms operating outside the post-shortage framework.
This means the most important question about any compounded GLP-1 platform in 2026 — including all three platforms in this comparison — is whether the platform's current compounding operation is operating within the current regulatory framework. That's a question to ask the platform directly and confirm with your prescribing clinician. No comparison article — including this one — can answer it for you in real time.
For a deeper breakdown of what compounded GLP-1 actually means in 2026, see: What Compounded Semaglutide Actually Means: A Plain-Language Guide for 2026.
Refills Health
Structure: Technology platform connecting patients to independent licensed clinicians through partner networks — Beluga Health, Bask Health, and Wasef Health, per the company's own published disclaimer. Refills is not the healthcare provider — the independent clinician is. Verticals offered: Weight loss (compounded GLP-1 plus brand-name pathways), better intimacy (Tadalafil, Sildenafil, Cialis, Viagra), daily health (NAD+, Sermorelin, Methylene Blue), hair growth (Finasteride, Oral Minoxidil, combination spray). Starting price: Marketing positions GLP-1 access from approximately $5/day, which works out to around $150/month at the entry tier per published pricing — a 40 percent spring sale was being marketed at the time of this review. Billing: Cash-pay only, no insurance billed directly. Prescription medications non-returnable once dispensed (a regulatory standard). Cancellation permitted before the prescription is sent to the pharmacy. Geographic coverage: 50 states (Washington D.C. excluded). Support: 888-458-5061 and [email protected].
What stands out: Refills publicly names three clinical partners (Beluga, Bask, Wasef), which is more transparent than most multi-vertical platforms in this category. The published return and cancellation policy is unusually detailed for a telehealth brand. The four-vertical breadth genuinely differentiates from GLP-1-specialist platforms. What to verify: The “starts at $5/day” framing maps to the entry tier — actual cost depends on the specific dose and formulation prescribed. The Daily Health category (NAD+, Sermorelin, Methylene Blue) sits in a thinner peer-reviewed evidence space than the established GLP-1 or ED categories, so a meaningful clinician conversation matters more for those. The platform's independent review footprint is newer than LifeMD's.
MEDVi
Structure: Three-entity telehealth model — platform plus independent licensed clinicians plus partner compounding pharmacies. MEDVi has positioned itself as one of the lower-priced compounded GLP-1 options in the cash-pay market. Verticals offered: Primarily focused on GLP-1 weight loss and metabolic health, with a more concentrated category set than Refills. Starting price: Compounded semaglutide has been published around $129/month based on publicly available pricing at time of research — confirm current pricing directly, as MEDVi adjusts pricing frequently. Billing: Subscription-based recurring billing. Cash-pay model. Geographic coverage: Broad U.S. availability, with some state exclusions. Support: Clinical messaging through the MEDVi platform.
What stands out: MEDVi's published entry pricing is among the lowest in the cash-pay compounded GLP-1 segment. The platform is more focused than Refills, which can be a feature for patients who only want GLP-1 and don't need the multi-vertical structure. What to verify: The narrow category focus means MEDVi is not a substitute if you also want hair loss or ED prescriptions through the same login. Independent review footprint is similarly newer than LifeMD's. The same compounded GLP-1 regulatory caveats apply.
LifeMD
Structure: LifeMD operates with a more established clinical infrastructure, including an in-house clinical team rather than a pure platform-plus-partners model. The platform has been active in telehealth since well before the GLP-1 boom. Verticals offered: Weight management (including pathways to FDA-approved Wegovy and Zepbound for eligible insured patients, alongside compounded options), primary care, men's health, women's health, and a broader chronic care infrastructure than the typical GLP-1-focused platform. Starting price: LifeMD's GLP-1 program pricing involves a separate membership fee on top of medication cost. Total monthly cost depends on the specific medication pathway, the membership tier, and whether insurance is being applied. Confirm current pricing directly. Billing: Membership-plus-medication structure. Insurance pathways available for some FDA-approved medications. Geographic coverage: Broad U.S. availability. Support: In-platform messaging plus scheduled consultations.
What stands out: LifeMD's commitment to having a pathway to FDA-approved brand-name medications (not just compounded) is a meaningful differentiator in 2026, when the regulatory status of compounded programs continues to evolve. The in-house clinical team and broader chronic care infrastructure make LifeMD closer to a digital primary care platform than a pure telehealth prescription platform. The independent review footprint is the largest of the three platforms in this comparison. What to verify: The membership fee structure is a real cost on top of medication and changes the apples-to-apples pricing comparison with Refills and MEDVi. The broader infrastructure also means a more committed engagement model — if you wanted a quick prescription pathway, the membership requirement is friction.
How to Choose
If you want multi-category coverage in a single login and prefer cash-pay simplicity: Refills Health's four-vertical model fits this case directly. Go in knowing the prescription return restrictions and the standard compounded GLP-1 caveats.
If GLP-1 is the only category you need and budget is the dominant factor: MEDVi's $129 entry tier is among the lowest in the cash-pay compounded segment. The narrow category focus means it doesn't replace the multi-vertical login if you also want hair loss or ED access.
If you want insurance support, FDA-approved brand-name medications, or a more committed clinical engagement: LifeMD's structure supports that. The membership-plus-medication pricing model is real cost to factor in, but the larger independent review footprint and the broader care infrastructure are meaningful differentiators.
If you have complex medical history or want intensive clinical oversight: None of the three platforms above replace a dedicated obesity medicine specialist. Platforms like Form Health and Calibrate are structured differently — with physician-led programs designed specifically for patients with obesity as a primary medical diagnosis. My broader program comparison covers those options: Best GLP-1 Telehealth Programs 2026: What to Know Before You Choose.
For the GLP-1-specialist platform comparison (Wellorithm, Hims, Ro), which is structured for patients who already know they want GLP-1 only, see: Wellorithm vs. Hims and Ro.
For the deeper breakdown of Refills Health pricing structure across dose escalations, see: Refills GLP-1 Cost and Billing: A 2026 Patient Guide.
Frequently Asked Questions
What is the cheapest of Refills Health, MEDVi, and LifeMD for GLP-1?
Based on published pricing at the time of this review, Refills Health markets GLP-1 access from approximately $5 per day (around $150 per month at the entry tier). MEDVi has been published around $129 per month for compounded semaglutide. LifeMD's GLP-1 program pricing varies and includes a separate membership fee on top of medication cost. Confirm current pricing directly with each platform — rates change frequently in this category.
What is the difference between Refills Health and LifeMD?
Both are multi-vertical telehealth platforms, but they differ in clinical model and program structure. Refills Health connects patients with independent clinicians through partner networks (Beluga Health, Bask Health, Wasef Health) on a cash-pay basis. LifeMD operates with its own clinical team, offers a structured membership model that includes ongoing access fees in addition to medication, and supports insurance pathways for some FDA-approved medications. The membership component and the insurance pathway are the most meaningful differentiators.
Which multi-vertical telehealth platform is best in 2026?
There is no single best platform. The right choice depends on which categories you actually need (GLP-1 only, GLP-1 plus hair loss, GLP-1 plus ED, etc.), your budget, whether you prefer cash-pay or insurance-supported access, and the level of ongoing clinical engagement your situation requires. Use this comparison as a framework for evaluating which structure fits your situation, then confirm current program terms directly with the platform before enrolling.
Are all three platforms compounded GLP-1 only?
No. Refills Health and MEDVi primarily route GLP-1 patients to compounded options. LifeMD operates with broader pathways including FDA-approved brand-name medications for eligible patients with insurance support. Refills also lists brand-name medications such as Ozempic, Wegovy, and Zepbound on its homepage, but these are prescription pathways subject to clinician evaluation, not over-the-counter availability.
Leave a Reply
You must be logged in to post a comment.